ArticleScientific reports2025
Dose-dependent effects of wheat germ oil and vitamin E on apoptosis and gene expression in breast and cervical cancer cell lines with single-cell RNA-seq profiling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wheat Bioactive Compounds and Human Health: A Review of Nutraceutical Potential, Molecular Mechanisms and AI-Assisted Functional Food Innovation.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The search for natural sources has raised hopes for a natural metabolite with fewer side effects in the treatment of cancers. Therefore, this study investigated the therapeutic effects of different doses of wheat germ oil (WGO) and α-tocopherol (vitamin E) on MCF-7 and HeLa cell lines through the expression of apoptosis genes and Single-cell RNA seq analysis (scRNA-seq). Cells were treated with WGO (15 µg/ml, 7.5 µg/ml and 3.75 µg/ml) and α-tocopherol concentrations for 14 days after plating in cell culture plates. After that, apoptotic cells were examined using flow cytometry with Annexin V-FITC and PI staining. Cell cycle analysis was performed by flow cytometry, expression analysis of BAX, BCL-2 and P53 genes by real-time PCR (RT-PCR), and scRNA-seq of cervical cancer cells were evaluated. Concentrations of 15 µg/ml and 7.5 µg/ml WGO and α-tocopherol led to an increase in necrotic and apoptotic cells and a decrease in viable cells in MCF-7 and HeLa cell lines (p < 0.05). While the concentration of 3.75 µg/ml did not show a significant effect (p > 0.05). In addition, gene expression analysis showed that treatment with different concentrations of WGO and α-tocopherol significantly reduced BCL-2 gene expression (p < 0.05) and increased P53 and BAX gene expression in both cell lines (p < 0.05). The study highlights the beneficial effects of high doses of WGO (15 and 7.5 µg/mL) and α-tocopherol in MCF-7 and HeLa cell lines by examining cell viability, apoptosis and necrosis, and apoptotic pathway genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.